Latest Company Financials News

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.

Global X Metal Securities Australia Limited has issued a prospectus for five classes of securities tracking gold, silver, platinum, palladium, and a precious metals basket. The securities are physically backed, traded on ASX under AQUA Rules, and managed by JPMorgan Chase Bank.

Neurotech International has secured FDA clearance for its NTI164 Investigational New Drug application and obtained Notices of Allowance for two US patents, advancing its Phase 3 autism spectrum disorder program.

Aeris Resources reported FY26 copper equivalent production of 42.1kt and gold output of 49koz, both comfortably within guidance, while ending the year with a robust cash and receivables balance of $202.3 million.

Orthocell Limited has posted record revenue for FY2026, driven by strong sales growth of Remplir™ and Striate+™ products in Australia, the US, and new international markets, supported by a robust $44.1 million cash position.

Australian Strategic Materials Limited (ASM) shareholders are set to vote on a scheme of arrangement for Energy Fuels Inc. to acquire 100% of ASM shares and options, offering a significant premium and exposure to a vertically integrated rare earth supply chain.

Chrysos Corporation has hit a new milestone with over one million samples processed monthly, driven by expanding lease agreements and deployments of its PhotonAssay technology. The company remains on track for FY26 revenue and EBITDA guidance amid accelerating global growth.

Duketon Mining has kicked off its maiden drilling program at the Barlee Gold Project, targeting multiple large gold anomalies, while reporting a combined nickel resource exceeding 100,000 tonnes across its Rosie and C2 deposits.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.

D3 Energy has raised $6.12 million through a strongly supported placement at a significant premium to its IPO price, aiming to accelerate exploration and development of its helium assets amid tightening global supply.

Pantoro Gold has reported a robust first half of FY2026 with record EBITDA and cash flow, while revising full-year production guidance due to weather and operational transitions. The appointment of Redpath as sole underground contractor signals a strategic move to streamline operations and support future growth.

Memphasys Limited has advanced its Felix™ System commercial rollout with key regulatory approvals and new international contracts, while trimming operating costs and narrowing losses in the first half of FY2026.